Home/Filings/4/0001562180-24-008424
4//SEC Filing

Kuriakose Emil 4

Accession 0001562180-24-008424

CIK 0001831363other

Filed

Dec 15, 7:00 PM ET

Accepted

Dec 16, 6:26 PM ET

Size

5.8 KB

Accession

0001562180-24-008424

Insider Transaction Report

Form 4
Period: 2024-12-12
Kuriakose Emil
Chief Medical Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2024-12-12+120,000120,000 total
    Exercise: $6.59Exp: 2034-12-11Common Stock (120,000 underlying)
Footnotes (1)
  • [F1]25% of the shares subject to the option vest on the first anniversary measured from December 12, 2024 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested on the fourth anniversary of the Vesting Commencement Date.

Issuer

Terns Pharmaceuticals, Inc.

CIK 0001831363

Entity typeother

Related Parties

1
  • filerCIK 0001892413

Filing Metadata

Form type
4
Filed
Dec 15, 7:00 PM ET
Accepted
Dec 16, 6:26 PM ET
Size
5.8 KB